$368.16 +3.72 (%) Regeneron Pharmaceuticals Inc - NASDAQ

Jan. 13, 2017 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Odds Are Against Regeneron, Sanofi In Amgen Patent Battle: Leerink

    Investors Business Daily | Jan. 13, 2017 | 13:49PM EST
  2. Nasdaq, S&P 500 Hit All-Time Highs; FANG Stocks Show Some Bite

    Investors Business Daily | Jan. 6, 2017 | 15:08PM EST
  3. Could Sanofi Acquire BioMarin In Wake Of Amgen LDL Brouhaha?

    Investors Business Daily | Jan. 6, 2017 | 14:56PM EST
  4. Regeneron, Sanofi Hammered After Judge Bans Amgen-Rivaling LDL-Buster

    Investors Business Daily | Jan. 6, 2017 | 12:45PM EST
  5. Disney's 'Tide Is Turning' But GoPro, McDonald's Served Downgrades

    Investors Business Daily | Jan. 6, 2017 | 09:27AM EST
  6. Stock Futures Ease, Dollar Climbs; Early Risers: Amgen, Ionis, Verizon

    Investors Business Daily | Jan. 6, 2017 | 08:05AM EST
  7. Regeneron, Sanofi LDL-Buster At Risk After Judge Upholds Amgen Patents

    Investors Business Daily | Jan. 4, 2017 | 11:26AM EST
  8. Intro Guide To The Fidelity Select Biotechnology Fund (FBIOX)

    TalkMarkets | Dec. 21, 2016 | 05:54AM EST
  9. Regeneron Likely To Jump On Amgen LDL-Buster, But Expectations Too High

    Investors Business Daily | Dec. 20, 2016 | 15:28PM EST
  10. Morning Call For Tuesday, Dec. 20

    TalkMarkets | Dec. 20, 2016 | 08:54AM EST
  11. Regeneron Could Add $604 Million To 2018 Top Line On Eczema: RBC

    Investors Business Daily | Dec. 13, 2016 | 16:17PM EST
  12. The Basics: Why Industry Loves Company, And Leading Stocks Travel In Groups

    Investors Business Daily | Dec. 13, 2016 | 14:34PM EST
  13. Biotechs Mixed Hurt By Alexion And Ophthotech

    TalkMarkets | Dec. 12, 2016 | 23:03PM EST
  14. Regeneron Spikes On Blurry-Eye Win Vs. Failed Ophthotech Drug

    Investors Business Daily | Dec. 12, 2016 | 13:34PM EST
  15. Biotechs Unhinged By Tough Pricing Talk

    TalkMarkets | Dec. 8, 2016 | 23:04PM EST
  16. Biotechs 'Round-Trip' Trump-Inspired Rally; FDA Appointment Key

    Investors Business Daily | Dec. 8, 2016 | 15:39PM EST
  17. Play The Trump Factor With These 4 Large-Cap Stocks

    TalkMarkets | Dec. 6, 2016 | 14:38PM EST
  18. Amgen, Regeneron 2017 LDL-Busters Could Boost This Small-Cap Biotech

    Investors Business Daily | Dec. 2, 2016 | 13:57PM EST
  19. Biotechs Aerie, Medicines Co., Tesaro Could Rocket, Or Be Bought: RBC

    Investors Business Daily | Dec. 1, 2016 | 14:14PM EST
  20. Biotech Stocks Soar on Election Results, Gilead HBV Drug Approved

    TalkMarkets | Nov. 16, 2016 | 15:30PM EST
  21. Biotech Meltdown: Financial Metrics Offer Few Clues For What is Next

    TalkMarkets | Nov. 1, 2016 | 06:52AM EST
  22. Sanofi (SNY) Beats Earnings, Revenues Rise Y/Y; Ups View

    TalkMarkets | Oct. 31, 2016 | 12:05PM EST
  23. Regeneron trading down on Sanofi news, says Piper Jaffray

    TalkMarkets | Oct. 28, 2016 | 13:28PM EST
  24. Biotech Stock Roundup: Ariad Down On Drug Pricing Tweet, Regeneron Study On Clinical Hold

    TalkMarkets | Oct. 19, 2016 | 14:27PM EST
  25. Before The Move: Ophthotech Worries Seen As Opportunity Ahead Of Phase 3 Data

    TalkMarkets | Oct. 4, 2016 | 14:29PM EST
  26. Top Stock Stories For Friday, Sept. 30

    TalkMarkets | Sep. 30, 2016 | 20:32PM EST
  27. Biotech ETFs Lead Q3 Rally: XBI Breaks Out

    TalkMarkets | Sep. 22, 2016 | 20:00PM EST
  28. Regeneron Stock Dips As Earnings Beat And Revenue Lags

    Investors Business Daily | Aug. 4, 2016 | 09:44AM EST
  29. Lilly, J&J, Novo Battle For Diabetes Market Heats Up; FDA Rulings Loom

    Investors Business Daily | Jul. 22, 2016 | 09:44AM EST
  30. Benzinga's Top Upgrades

    Benzinga | Feb. 16, 2016 | 08:57AM EST
  31. Biotech Stocks Slip As Hugely Popular Momentum ETF Makes A Big Change

    IBD | Feb. 9, 2016 | 12:41PM EST
  32. Regeneron Q4 Earnings Miss Estimates Amid Slow Praluent Launch

    IBD | Feb. 9, 2016 | 11:28AM EST
  33. Stock Futures Quietly Lower; Yamana Gold Continues Rally

    IBD | Feb. 9, 2016 | 08:55AM EST
  34. Why These Five Sector Leaders Became Former Leaders

    IBD | Feb. 8, 2016 | 16:30PM EST
  35. Benzinga's Top Downgrades

    Benzinga | Jan. 25, 2016 | 09:30AM EST
  36. SMR Rating Uncovers Stocks With Top Sales, Margins

    IBD | Jan. 20, 2016 | 16:50PM EST
  37. Medicines Company Spikes On Report Of Possible Sale

    IBD | Jan. 20, 2016 | 12:59PM EST
  38. Walgreens Exec Buys, CVS CEO Sells Amid Market Rout

    IBD | Jan. 15, 2016 | 15:00PM EST
  39. Stocks Reverse Higher To Big Gains; Intel Falls After Q4 Results

    IBD | Jan. 14, 2016 | 16:29PM EST
  40. Drug Stocks Mixed On Guidance Updates

    IBD | Jan. 12, 2016 | 18:45PM EST
  41. Horizon Up; Zoetis Trims EPS

    IBD | Jan. 12, 2016 | 18:40PM EST
  42. US Stock Futures Surge After Jobs Data

    Benzinga | Jan. 8, 2016 | 08:50AM EST
  43. U.S. Stock Futures Surge After Jobs Data; El-Erian To Discuss Economic Situation

    Benzinga | Jan. 8, 2016 | 08:50AM EST
  44. Regeneron, Sanofi Announce Sarilumab Biologics License Application Accepted for Review FDA

    Benzinga | Jan. 8, 2016 | 04:01AM EST
  45. Gilead Leads 3 Drug Stocks With Top Fundamentals

    IBD | Jan. 7, 2016 | 08:02AM EST
  46. Alphabet, Palo Alto Networks Lead Week's Insider Deals

    IBD | Dec. 31, 2015 | 13:59PM EST
  47. The 5 Top-Performing Big-Cap Drug Stocks Of 2015

    IBD | Dec. 30, 2015 | 14:16PM EST
  48. Big Biotech Amgen Facing Pivotal Year In 2016

    IBD | Dec. 17, 2015 | 17:08PM EST
  49. Regeneron, Sanofi Announce UnitedHealth Group to Provide Preferred Access Praluent Injection

    Benzinga | Dec. 11, 2015 | 04:13AM EST
  50. GoPro Downgraded, Ambarella PT Cut, Biotechs Are Buys

    IBD | Dec. 4, 2015 | 08:53AM EST
Trading Center